News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
162,854 Results
Type
Article (10797)
Company Profile (46)
Press Release (152005)
Multimedia
Podcasts (45)
Webinars (12)
Section
Business (38749)
Career Advice (258)
Deals (6287)
Drug Delivery (38)
Drug Development (18012)
Employer Resources (34)
FDA (3703)
Job Trends (3340)
News (66747)
Policy (6572)
Tag
2027 Pharm Country Standard (1)
Academia (868)
Accelerated approval (13)
Adcomms (2)
Allergies (64)
Alliances (14022)
ALS (68)
Alzheimer's disease (735)
Antibody-drug conjugate (ADC) (108)
Approvals (3831)
Artificial intelligence (586)
Autoimmune disease (75)
Automation (27)
Bankruptcy (42)
Best Places to Work (2912)
BIOSECURE Act (10)
Biosimilars (71)
Biotechnology (29)
Bladder cancer (49)
Brain cancer (31)
Breast cancer (302)
Cancer (1933)
Cardiovascular disease (137)
Career advice (235)
Career pathing (12)
CAR-T (95)
CDC (9)
Cell therapy (284)
Cervical cancer (18)
Clinical research (15756)
Collaboration (1050)
Compensation (150)
Complete response letters (10)
COVID-19 (873)
CRISPR (40)
C-suite (272)
Cystic fibrosis (82)
Data (2325)
Decentralized trials (1)
Denatured (22)
Depression (40)
Diabetes (214)
Diagnostics (2446)
Digital health (28)
Diversity (4)
Diversity, equity & inclusion (7)
Drug discovery (170)
Drug pricing (61)
Drug shortages (6)
Duchenne muscular dystrophy (60)
Earnings (13489)
Editorial (22)
Employer branding (4)
Employer resources (30)
Events (20978)
Executive appointments (307)
FDA (4925)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (717)
Gene editing (95)
Generative AI (58)
Gene therapy (248)
GLP-1 (309)
Government (1401)
Grass and pollen (6)
Guidances (136)
Healthcare (5451)
HIV (50)
Huntington's disease (19)
IgA nephropathy (30)
Immunology and inflammation (70)
Immuno-oncology (20)
Indications (40)
Infectious disease (983)
Inflammatory bowel disease (84)
Inflation Reduction Act (6)
Influenza (45)
Intellectual property (82)
Interviews (47)
IPO (3167)
IRA (18)
Job creations (561)
Job search strategy (181)
JPM (27)
Kidney cancer (9)
Labor market (20)
Layoffs (105)
Leadership (15)
Legal (935)
Liver cancer (27)
Longevity (7)
Lung cancer (248)
Lymphoma (131)
Machine learning (39)
Management (15)
Manufacturing (290)
MASH (71)
Medical device (3657)
Medtech (3681)
Mergers & acquisitions (3517)
Metabolic disorders (474)
Multiple sclerosis (47)
NASH (4)
Neurodegenerative disease (139)
Neuropsychiatric disorders (36)
Neuroscience (1219)
Neurotech (1)
NextGen: Class of 2026 (1520)
Non-profit (1664)
Now hiring (11)
Obesity (189)
Opinion (112)
Ovarian cancer (38)
Pain (68)
Pancreatic cancer (92)
Parkinson's disease (129)
Partnered (19)
Patents (163)
Patient recruitment (226)
Peanut (31)
People (10958)
Pharmaceutical (14)
Pharmacy benefit managers (7)
Phase 1 (5165)
Phase 2 (7201)
Phase 3 (5061)
Pipeline (2040)
Policy (106)
Postmarket research (465)
Preclinical (2156)
Press Release (18)
Prostate cancer (105)
Psychedelics (12)
Radiopharmaceuticals (114)
Rare diseases (352)
Real estate (1103)
Recruiting (16)
Regulatory (5764)
Reports (16)
Research institute (880)
Resumes & cover letters (27)
Rett syndrome (12)
RNA editing (9)
RSV (31)
Schizophrenia (56)
Series A (121)
Series B (89)
Service/supplier (2)
Sickle cell disease (39)
Special edition (5)
Spinal muscular atrophy (36)
Sponsored (13)
Startups (951)
Stomach cancer (4)
Supply chain (43)
Tariffs (19)
The Weekly (23)
Vaccines (331)
Venture capital (45)
Weight loss (94)
Women's health (28)
Worklife (5)
Date
Today (8)
Last 7 days (226)
Last 30 days (866)
Last 365 days (10676)
2026 (1071)
2025 (10835)
2024 (11831)
2023 (12178)
2022 (17142)
2021 (17341)
2020 (15643)
2019 (11720)
2018 (8226)
2017 (6889)
2016 (6616)
2015 (7200)
2014 (4896)
2013 (3977)
2012 (4052)
2011 (4049)
2010 (3286)
Location
Africa (288)
Alabama (20)
Alaska (2)
Arizona (74)
Arkansas (6)
Asia (12306)
Australia (2045)
California (3382)
Canada (1086)
China (526)
Colorado (158)
Connecticut (213)
Delaware (119)
Europe (28951)
Florida (502)
Georgia (113)
Hawaii (2)
Idaho (13)
Illinois (262)
India (24)
Indiana (160)
Iowa (5)
Japan (201)
Kansas (26)
Kentucky (5)
Louisiana (11)
Maine (45)
Maryland (431)
Massachusetts (2786)
Michigan (69)
Minnesota (185)
Missouri (40)
Montana (7)
Nebraska (8)
Nevada (43)
New Hampshire (42)
New Jersey (742)
New Mexico (16)
New York (1040)
North Carolina (441)
North Dakota (3)
Northern California (1863)
Ohio (89)
Oklahoma (9)
Oregon (11)
Pennsylvania (689)
Puerto Rico (5)
Rhode Island (15)
South America (278)
South Carolina (7)
Southern California (1037)
Tennessee (51)
Texas (768)
United States (12728)
Utah (88)
Virginia (72)
Washington D.C. (22)
Washington State (407)
West Virginia (1)
Wisconsin (50)
162,854 Results for "zephyr ai".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Zephyr AI Appoints Watson Pharmaceuticals Founder Dr. Allen Chao as Chief Executive Officer
August 26, 2025
·
3 min read
Press Releases
L7 Informatics: Life Sciences Must Move from AI-Ready to AI-Actionable
Execution layers are required to turn AI recommendations into governed action in regulated workflows.
January 26, 2026
·
1 min read
Press Releases
As mental health patients turn to AI chatbots, how can pharma lead the way?
A new report by Bryter released today reveals where pharma can lead as patients turn to (and question) AI tools for mental health.
February 5, 2026
·
1 min read
Artificial intelligence
AI-Enabled Clinical Improvements Confirm Biotech Hype as Success Rates Rise
As drug candidates discovered via AI move into later-stage clinical trials, the technology seems to be doing as promised: speeding drug development.
January 21, 2026
·
3 min read
·
Annalee Armstrong
BioCapital
Zephyr AI Raises $111 Million in Series A Financing
Zephyr AI, Inc. today announced it has successfully closed a $111 million Series A funding round with participation from Revolution Growth, Eli Lilly & Co.
March 13, 2024
·
4 min read
Press Releases
EVQLV Launches Abtique, the First Marketplace for AI-Designed Molecules Validated in Independent Labs
New “click-to-sequence” platform lets researchers buy AI-designed antibody sequences online, using an AI system that learns from real lab results
November 20, 2025
·
1 min read
Insights
As FDA Deploys Agentic AI, Pharma Begins Testing the Next Frontier of Intelligent Automation
The agency’s sweeping rollout and staff challenge underscore rising momentum behind agentic AI: advanced, multiagent systems now fueling early pilots in medical writing, patient engagement and regulatory workflows across the industry.
December 8, 2025
·
3 min read
·
Jennifer Smith-Parker
Press Releases
Terray Therapeutics Achieves AI-Enabled Drug Discovery Milestone in Collaboration with Bristol Myers Squibb
Success demonstrates the power of EMMI, Terray’s proprietary AI platform integrated with its rapidly expanding 13B+ target-ligand binding database and highly automated lab
December 4, 2025
·
1 min read
Insights
New UK/EU Rules and AI Adoption Define CRO Priorities for 2026
With new UK clinical trial rules landing in 2026, the EU Biotech Act on the horizon and China and Australia gaining ground, CROs are zeroing in on study timelines, AI/ML and data privacy as the industry’s next pressure points.
December 3, 2025
·
4 min read
·
Jennifer Smith-Parker
IN PARTNERSHIP WITH CHARLES RIVER LABORATORIES
AI in CAR T Development: Lessons From the Front Lines
While the benefits of AI are clear, the amount data sets needed for effective AI integration is proving to be a challenge. This is particularly true for cell therapy companies as they are eagerly seeking ways to reduce development costs. Two experts at Charles River Laboratories provide insights by giving their takeaways from their own AI integrations.
October 13, 2025
·
5 min read
·
BioSpace Insights
1 of 16,286
Next